S
Subhash Padhye
Researcher at Savitribai Phule Pune University
Publications - 222
Citations - 12802
Subhash Padhye is an academic researcher from Savitribai Phule Pune University. The author has contributed to research in topics: Cancer & Copper. The author has an hindex of 56, co-authored 216 publications receiving 11480 citations. Previous affiliations of Subhash Padhye include National Chemical Laboratory & Poona College of Arts Science & Commerce.
Papers
More filters
Journal ArticleDOI
Thiosemicarbazone complexes of copper(II): structural and biological studies
Douglas X. West,Anthony E. Liberta,Subhash Padhye,Rajeev C. Chikate,Pramila Sonawane,Avinash S. Kumbhar,Ratnamala Yerande +6 more
TL;DR: In this paper, the authors discuss the biological importance of copper thiosemicarbazone complexes and their applications in the field of chemical engineering, such as chemical synthesis, chemical engineering and electrical engineering.
Journal ArticleDOI
Transition metal complexes of semicarbazones and thiosemicarbazones
TL;DR: In this paper, Generals survey has shown that thiosemicarbazone complexes can be formed by transition metal complexes, including d2 complexes, d3 complexes and d4 complexes.
Book ChapterDOI
Structural and physical correlations in the biological properties of transition metal heterocyclic thiosemicarbazone and S -alkyldithiocarbazate complexes
TL;DR: The nature of metal complexes of heterocyclic thiosemicarbazones reported in the literature through 1989 have been reviewed with an emphasis on variations in stoichiometry and stereochemistry as discussed by the authors.
Journal ArticleDOI
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.
Shadan Ali,Aamir Ahmad,Sanjeev Banerjee,Subhash Padhye,Kristin Dominiak,Jacqueline M. Schaffert,Zhiwei Wang,Philip A. Philip,Fazlul H. Sarkar +8 more
TL;DR: A significant reduction in cell viability was revealed in CDF-treated cells compared with curcumin- treated cells, which were also associated with the induction of apoptosis, and these results were consistent with the downregulation of Akt, cyclooxygenase-2, prostaglandin E(2), vascular endothelial growth factor, and NF-kappaB DNA binding activity.
Journal ArticleDOI
Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells.
Shreelekha Adsule,Vivek Barve,Di Chen,Fakhara Ahmed,Q. Ping Dou,Subhash Padhye,Fazlul H. Sarkar +6 more
TL;DR: It is found that quinoline thiosemicarbazone 2 was the most potent and inhibited proteosome activity in intact human prostate cancer PC-3 and LNCaP cells (IC50 of 4 and 3.2 microM, respectively) compared to clioquinol and pyrrolidine dithiocarbamate.